retatrutide and semaglutide vs. Tirzepatide vs. Comparing the Big 3, Semaglutide,

Studies from Novo Nordisk show an almost 25% reduction in adverse kidney outcomes for diabetes patients with CKD, and the company is trying to get Wegovys indications expanded to include CKD before years end

Safety results show which side effects occurred and how often participants stopped treatment

Reviewers typically look for an HbA1c at or above 7.0 percent for type 2 diabetes coverage, a BMI of 27 or higher with a comorbidity or 30 or higher standalone, a documented trial of metformin or another agent, and cardiovascular history such as coronary artery disease, stroke, or heart failure

Monitor blood glucose levels more frequently, check ketones if advised by your healthcare team, and consider temporarily adjusting other diabetes medications (particularly insulin, metformin or SGLT2 inhibitors) after seeking clinical advice if you're unable to eat or drink normally